Organovo, a biotechnology company headquartered in San Diego, is the
dominating market leader in the bioprinting technology as of today.
Although the first bioprinter was created in 2008 by Professor Makoto
Nakamura, Organovo is expected to continue to dominate the bioprinting
markets with their breakthrough developments of the product. Recently,
Organovo has applied for and owns patents for “multilayered vascular
tubes” and “self-assembling multicellular bodies and methods of
producing a three-dimensional structure using the same”. Organovo’s
NovoGen MMX Bioprinter was also acknowledged as one of the best
inventions in 2010 by TIME magazine.
This comment has been removed by the author.
ReplyDelete